Literature DB >> 21439219

Torticollis in mice intravenously infected with Mycobacterium tuberculosis.

Elizabeth R Magden1, Cristina M Weiner, Janet C Gilliland, Mary Ann DeGroote, Anne J Lenaerts, Lon V Kendall.   

Abstract

Female BALB/cAnNCrl (n = 170; age, 6 to 9 wk) mice were infected by intravenous inoculation of 5 × 10(6) cfu Mycobacterium tuberculosis strain Erdman (ATCC 35801). Between day 52 and 5 mo after infection, 10 of the 170 mice infected according to this protocol developed torticollis, including mice in treatment groups that received combination antibiotic therapy of rifampin-pyrazinamide or moxifloxacin-rifampin-pyrazinamide. Torticollis did not develop in mice receiving isoniazid- rifampin-pyrazinamide therapy, nor was it present in the cohort of aerogenically infected mice. Affected mice were euthanized, and complete necropsy evaluation was performed on 4 mice. Gross necropsy evaluation revealed typical tuberculosis lesions in lungs of infected mice. Histologic evaluation of tissues revealed granulomatous otitis media with intralesional acid-fast bacilli consistent with Mycobacterium tuberculosis. These cases represent an unusual finding specific to the intravenous mouse model of Mycobacterium tuberculosis and may represent a model of a similar condition in humans that is known as tuberculous otitis media.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439219      PMCID: PMC3061426     

Source DB:  PubMed          Journal:  J Am Assoc Lab Anim Sci        ISSN: 1559-6109            Impact factor:   1.232


  21 in total

1.  The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity.

Authors:  P J Cardona; A Cooper; M Luquín; A Ariza; F Filipo; I M Orme; V Ausina
Journal:  Scand J Immunol       Date:  1999-04       Impact factor: 3.487

2.  Tuberculous otitis media with facial nerve paralysis in an infant: a case of maternal transmission.

Authors:  Sung-Hwan Park; Eui-Kyung Goh; Soo-Keun Kong; Jong-Kil Lee
Journal:  Otolaryngol Head Neck Surg       Date:  2010-03-03       Impact factor: 3.497

Review 3.  The pathogenesis of tuberculosis: the first one hundred (and twenty-three) years.

Authors:  Neil W Schluger
Journal:  Am J Respir Cell Mol Biol       Date:  2005-04       Impact factor: 6.914

Review 4.  Preclinical testing of new vaccines for tuberculosis: a comprehensive review.

Authors:  Ian M Orme
Journal:  Vaccine       Date:  2005-08-08       Impact factor: 3.641

5.  Animal models of tuberculosis.

Authors:  U D Gupta; V M Katoch
Journal:  Tuberculosis (Edinb)       Date:  2005-10-24       Impact factor: 3.131

Review 6.  Immune responses to tuberculosis in developing countries: implications for new vaccines.

Authors:  Graham A W Rook; Keertan Dheda; Alimuddin Zumla
Journal:  Nat Rev Immunol       Date:  2005-08       Impact factor: 53.106

7.  Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route.

Authors:  R J North
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

8.  Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.

Authors:  J B Bass; L S Farer; P C Hopewell; R O'Brien; R F Jacobs; F Ruben; D E Snider; G Thornton
Journal:  Am J Respir Crit Care Med       Date:  1994-05       Impact factor: 21.405

Review 9.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

10.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.